This study aims to deepen the underlying mechanism of the interaction between KLF4 and SIAT7A in the progression of Ang II‐induced cardiac hypertrophy, with potential implications for the identification of novel therapeutic targets in clinical settings. The gene discussed is KLF4; the disease is cardiac hypertrophy.